University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Items where Author is "Russell-Jones, D"

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 75.

Article

Herring, R, Knight, R, Shojaee-Moradie, F, Johnsen, S, Umpleby, AM, Jackson, N, Jones, R, Dijk, DJ and Russell-Jones, DL (2015) Effect of Subcutaneous Insulin Detemir on Glucose Flux, Lipolysis and Electroencephalography in Type 1 Diabetes. Diabetes Obes Metab.

Herring, RA, Shojaee-Moradie, F, Umpleby, AM, Jones, R, Jackson, N and Russell-Jones, DL (2015) Effect of subcutaneous insulin detemir on glucose flux and lipolysis during hyperglycaemia in people with type 1 diabetes DIABETES OBESITY & METABOLISM, 17 (5). pp. 459-467.

Miras, AD, Mogford, JT, Wright, J, Mendoza, NN, Xekouki, P, Lakhani, A, Pellegata, NS, Stratakis, CA, Roncaroli, F and Russell-Jones, D (2015) Ovarian hyperstimulation from ectopic hypersecretion of follicle stimulating hormone LANCET, 385 (9965). p. 392.

Bodinham, CL, Smith, L, Thomas, EL, Bell, JD, Swann, JR, Costabile, A, Russell-Jones, D, Umpleby, AM and Robertson, MD (2014) Efficacy of increased resistant starch consumption in human type 2 diabetes ENDOCRINE CONNECTIONS, 3 (2). pp. 75-84.

Herring, R, Shojaee-Moradie, F, Jackson, N, Jones, R, Umpleby, AM and Russell-Jones, DL (2013) The effects of subcutaneous neutral protamine Hagedorn (NPH) insulin on glucose metabolism following a period of insulin withdrawal in patients with Type 1 diabetes DIABETIC MEDICINE, 30. pp. 15-16.

Robertson, Margaret, Russell-Jones, David, Umpleby, A and Dijk, Derk-Jan (2013) Effects of three weeks of mild sleep restriction implemented in the home environment on multiple metabolic and endocrine markers in healthy young men Metabolism: Clinical and Experimental, 62 (2). pp. 204-211.

Herring, R, Russell-Jones, DL, Pengilley, C, Hopkins, H, Tuthill, B, Wright, J, Hordern, SV and Davidson, S (2013) Management of raised glucose, a clinical decision tool to reduce length of stay of patients with hyperglycaemia. Diabet Med, 30 (1). pp. 81-87.

Russell-Jones, D and Gough, S (2012) Recent advances in incretin-based therapies. Clin Endocrinol (Oxf), 77 (4). pp. 489-499.

Robertson, MD, Wright, JW, Loizon, E, Debard, C, Vidal, H, Shojaee-Moradie, F, Russell-Jones, D and Umpleby, AM (2012) Insulin-sensitizing effects on muscle and adipose tissue after dietary fiber intake in men and women with metabolic syndrome. J Clin Endocrinol Metab, 97 (9). pp. 3326-3332.

Niswender, K, Pi-Sunyer, X, Buse, J, Jensen, KH, Toft, AD, Russell-Jones, D and Zinman, B (2012) Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme. Diabetes Obes Metab.

Nobes, JP, Langley, SE, Klopper, T, Russell-Jones, D and Laing, RW (2012) A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy. BJU Int, 109 (10). pp. 1495-1502.

Heller, S, Buse, J, Fisher, M, Garg, S, Marre, M, Merker, L, Renard, E, Russell-Jones, D, Philotheou, A, Francisco, AM, Pei, H, Bode, B and BEGIN Basal-Bolus Type 1 Trial Investigators, (2012) Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. Lancet, 379 (9825). pp. 1489-1497.

Backhouse, K, Sarac, I, Shojaee-Moradie, F, Stolinski, M, Robertson, MD, Frost, GS, Bell, JD, Thomas, EL, Wright, JW, Russell-Jones, D and Umpleby, AM (2012) Fatty acid flux and oxidation is increased by rimonabant in obese women Metabolism-Clinical and Experimental.

Gouet, D, Renard, E, Garber, A, Heller, S, Hollander, P, King, A, Russell-Jones, D, Pei, H, Franscisco, AM, Endahl, L and Marre, M (2012) Degludec insulin compared to glargin insulin diminishes the number of nocturnal hypoglycemic episodes: results after 1 year in randomized basal-bolus trials in type 1 (DT1) and type 2 (DT2) diabetics DIABETES & METABOLISM, 38. A9-A10.

Russell-Jones, D, Cuddihy, RM, Hanefeld, M, Kumar, A, González, JG, Chan, M, Wolka, AM, Boardman, MK and DURATION-4 Study Group, (2012) Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study. Diabetes Care, 35 (2). pp. 252-258.

Sennik, D, Ahmed, F and Russell-Jones, D (2012) Exenatide, a GLP-1 agonist in the treatment of Type 2 diabetes Expert Review of Endocrinology and Metabolism, 7 (1). pp. 15-26.

de Lusignan, S, Sadek, N, Mulnier, H, Tahir, A, Russell-Jones, D and Khunti, K (2012) Miscoding, misclassification and misdiagnosis of diabetes in primary care. Diabet Med, 29 (2). pp. 181-189.

Ahmed, FW, Ehsanullah, U, Sennik, D and Russell-Jones, D (2011) Skin problem in the diabetic clinic Practical Diabetes, 28 (8). p. 346.

Hansen, BF, Kurtzhals, P, Jensen, AB, Dejgaard, A and Russell-Jones, D (2011) Insulin X10 revisited: a super-mitogenic insulin analogue. Diabetologia, 54 (9). pp. 2226-2231.

Gough, SC, Belda-Iniesta, C, Poole, C, Weber, M, Russell-Jones, D, Hansen, BF, Mannucci, E and Tuomilehto, J (2011) Insulin therapy in diabetes and cancer risk: current understanding and implications for future study: proceedings from a meeting of a European Insulin Safety Consensus Panel, convened and sponsored by Novo Nordisk, held Tuesday October 5, 2010 at The Radisson Edwardian Heathrow Hotel, Hayes, Middlesex, UK. Adv Ther, 28 Sup. pp. 1-18.

Zachariah, S, Sheldon, B, Shojaee-Moradie, F, Jackson, NC, Backhouse, K, Johnsen, S, Jones, RH, Umpleby, AM and Russell-Jones, DL (2011) Insulin detemir reduces weight gain as a result of reduced food intake in patients with type 1 diabetes. Diabetes Care, 34 (7). pp. 1487-1491.

Soulsby, H and Russell-Jones, D (2010) Does diabetes put you at risk of tetanus? Practical Diabetes International, 27 (9). pp. 381-382.

Russell-Jones, D (2010) The safety and tolerability of GLP-1 receptor agonists in the treatment of type-2 diabetes. Int J Clin Pract, 64 (10). pp. 1402-1414.

Pollak, M and Russell-Jones, D (2010) Insulin analogues and cancer risk: cause for concern or cause célèbre? Int J Clin Pract, 64 (5). pp. 628-636.

Herring, R and Russell-Jones, D (2010) The effect of growth hormone on pituitary tumour growth Current Opinion in Endocrinology, Diabetes and Obesitysity.

Blonde, L and Russell-Jones, D (2009) The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies. Diabetes Obes Metab, 11 Sup. pp. 26-34.

Russell-Jones, D (2009) The role of incretin-based therapies in the management of type 2 diabetes Practical Diabetes International, 26 (5).

Smeeton, F, Shojaee Moradie, F, Jones, RH, Westergaard, L, Haahr, H, Umpleby, AM and Russell-Jones, DL (2009) Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes. Diabetologia, 52 (11). pp. 2317-2323.

Russell-Jones, D, Vaag, A, Schmitz, O, Sethi, BK, Lalic, N, Antic, S, Zdravkovic, M, Ravn, GM, Simó, R and Liraglutide Effect and Action in Diabetes 5 (LEAD-5) met+SU Stud, (2009) Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial. Diabetologia, 52 (10). pp. 2046-2055.

De Vries, CS and Russell-Jones, DL (2009) Rosiglitazone or pioglitazone in type 2 diabetes? BMJ (Online), 339 (7720). p. 524.

Hermansen, K, Heller, S, Andersen, M and Russell-Jones, DL (2009) Lower rate of hypoglycaemia but comparable glycaemic control with insulin detemir compared to NPH insulin in patients with type 1 diabetes DIABETOLOGIA, 52. S359-S359.

Higham, CE, Rowles, S, Russell-Jones, D, Umpleby, AM and Trainer, PJ (2009) Pegvisomant improves insulin sensitivity and reduces overnight free fatty acid concentrations in patients with acromegaly. J Clin Endocrinol Metab, 94 (7). pp. 2459-2463.

Brackenridge, AL, Jackson, N, Jefferson, W, Stolinski, M, Shojaee-Moradie, F, Hovorka, R, Umpleby, AM and Russell-Jones, D (2009) Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids DIABETIC MEDICINE, 26 (5). pp. 532-539.

Russell-Jones, D (2009) Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue MOLECULAR AND CELLULAR ENDOCRINOLOGY, 297 (1-2). pp. 137-140.

Sheldon, B, Russell-Jones, D and Wright, J (2009) Insulin analogues: an example of applied medical science DIABETES OBESITY & METABOLISM, 11 (1). pp. 5-19.

de Vries, C, Snowball, J, Russell-Jones, D and Hutchison, A (2008) Stillbirth and early neonatal death risk is reduced in those using analogue compared with those using human insulin PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 17. S15-S15.

Hilton, C, Russell-Jones, D, Hordern, V and Williams, J (2008) Has the nGMS contract improved diabetes care in general practice? Diabetes and Primary Care, 10 (2). pp. 83-86.

Russell-Jones, D and Khan, R (2007) Insulin-associated weight gain in diabetes - causes, effects and coping strategies DIABETES OBESITY & METABOLISM, 9 (6). pp. 799-812.

Zachariah, S, Brackenridge, A, Shojaee-Moradie, F, Camuncho-Hubner, C, Umpleby, AM and Russell-Jones, D (2007) The mechanism of non-islet cell hypoglycaemia caused by tumour-produced IGF-II CLINICAL ENDOCRINOLOGY, 67 (4). pp. 637-638.

Russell-Jones, DL (2007) Insulin detemir and basal insulin therapy. Endocrinol Metab Clin North Am, 36 Sup. pp. 7-13.

McMillan, CV, Bradley, C, Gibney, J, Russell-Jones, DL and Sönksen, PH (2006) Preliminary development of the new individualized HDQoL questionnaire measuring quality of life in adult hypopituitarism. J Eval Clin Pract, 12 (5). pp. 501-514.

Brackenridge, A, Wallbank, H, Lawrenson, RA and Russell-Jones, D (2006) Emergency management of diabetes and hypoglycaemia EMERGENCY MEDICINE JOURNAL, 23 (3). pp. 183-185.

Christ, ER, Cummings, MH, Stolinski, M, Jackson, N, Lumb, PJ, Wierzbicki, AS, Sonksen, PH, Russell-Jones, DL and Umpleby, AM (2006) Low-density lipoprotein apolipoprotein B100 turnover in hypopituitary patients with GH deficiency: a stable isotope study EUROPEAN JOURNAL OF ENDOCRINOLOGY, 154 (3). pp. 459-466.

Brackenridge, A, Pearson, ER, Shojaee-Moradie, F, Hattersley, AT, Russell-Jones, D and Umpleby, AM (2006) Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1 beta and -1 alpha mutations DIABETES, 55 (2). pp. 405-411.

Healy, ML, Gibney, J, Pentecost, C, Croos, P, Russell-Jones, DL, Sonken, PH and Umpleby, AM (2006) Effects of high-dose growth hormone on glucose and glycerol metabolism at rest and during exercise in endurance-trained athletes JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 91 (1). pp. 320-327.

McMillan, CV, Bradley, C, Gibney, J, Russell-Jones, DL and Sönksen, PH (2006) Psychometric properties of two measures of psychological well-being in adult growth hormone deficiency. Health Qual Life Outcomes, 4.

Hordern, SVM, Wright, JE, Umpleby, AM, Shojaee-Moradie, F, Amiss, J and Russell-Jones, DL (2005) Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-h euglycaemic clamp DIABETOLOGIA, 48 (3). pp. 420-426.

Simpson, HL, Jackson, NC, Shojaee-Moradie, F, Jones, RH, Russell-Jones, DL, Sonksen, PH, Dunger, DB and Umpleby, AM (2004) Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 89 (1). pp. 425-432.

Carroll, PV, Jackson, NC, Russell-Jones, DL, Treacher, DF, Sönksen, PH and Umpleby, AM (2004) Combined growth hormone/insulin-like growth factor I in addition to glutamine-supplemented TPN results in net protein anabolism in critical illness. Am J Physiol Endocrinol Metab, 286 (1). E151-E157.

Hordern, VM, Wright, JE, Umpleby, M, Jacobsen, L, Draeger, E and Russell-Jones, DL (2002) Stable isotope studies show differences in effect of insulin detemir and NPH insulin on hepatic glucose output and peripheral glucose uptake after subcutaneous administration in subjects with type1 diabetes DIABETES, 51. A292-A292.

Umpleby, AM, Carroll, PV, Russell-Jones, DL, Treacher, DF and Jackson, NC (2002) Glutamine supplementation and GH/IGF-I treatment in critically ill patients: effects on glutamine metabolism and protein balance. Nutrition, 18 (2). pp. 127-129.

Hordern, V, Wright, J, Umpleby, M, Jacobsen, L and Russell-Jones, D (2001) Stable isotope studies show effect of insulin detemir and NPH on hepatic glucose output and peripheral glucose uptake after subcutaneous administration in healthy subjects DIABETES, 50. A504-A505.

Carroll, PV, Christ, ER, Umpleby, AM, Gowrie, I, Jackson, N, Bowes, SB, Hovorka, R, Croos, P, Sönksen, PH and Russell-Jones, DL (2000) IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp. Diabetes, 49 (5). pp. 789-796.

Jackson, NC, Carroll, PV, Russell-Jones, DL, Sönksen, PH, Treacher, DF and Umpleby, AM (2000) Effects of glutamine supplementation, GH, and IGF-I on glutamine metabolism in critically ill patients. Am J Physiol Endocrinol Metab, 278 (2). E226-E233.

Hovorka, R, Carroll, PV, Gowrie, IJ, Jackson, NC, Russell-Jones, DL and Umpleby, AM (1999) A surrogate measure of whole body leucine transport across the cell membrane. Am J Physiol, 276 (3 Pt 1). E573-E579.

Jackson, NC, Carroll, PV, Russell-Jones, DL, Sönksen, PH, Treacher, DF and Umpleby, AM (1999) The metabolic consequences of critical illness: acute effects on glutamine and protein metabolism. Am J Physiol, 276 (1 Pt 1). E163-E170.

Carroll, PV, Umpleby, M, Alexander, EL, Egel, VA, Callison, KV, Sonksen, PH and Russell-Jones, DL (1998) Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment CLINICAL ENDOCRINOLOGY, 49 (6). pp. 739-746.

Russell-Jones, DL, Bowes, SB, Rees, SE, Jackson, NC, Weissberger, AJ, Hovorka, R, Sonksen, PH and Umpleby, AM (1998) Effect of growth hormone treatment on postprandial protein metabolism in growth hormone-deficient adults. Am J Physiol, 274 (6 Pt 1). E1050-E1056.

Russell-Jones, DL, Umpleby, AM, Shojaee-Moradie, F, Boroujerdi, MA, Jones, RH, Baxter, RC and Sonksen, PH (1997) The effect of an intravenous infusion of IGF-I and insulin on IGFBP-1, IGFBP-3, acid labile subunit, free and bound IGF-I, catecholamines and potassium in normal volunteers during an amino acid and glucose clamp CLINICAL ENDOCRINOLOGY, 47 (6). pp. 685-691.

Carroll, PV, Umpleby, AM, Albany, E, Jackson, NC, Morgan-Hughes, JA, Sonksen, PH and Russell-Jones, DL (1997) Growth hormone therapy may benefit protein metabolism in mitochondrial encephalomyopathy. Clin Endocrinol (Oxf), 47 (1). pp. 113-117.

Bowes, SB, Umpleby, M, Cummings, MH, Jackson, NC, Carroll, PV, Lowy, C, Sönksen, PH and Russell-Jones, DL (1997) The effect of recombinant human growth hormone on glucose and leucine metabolism in Cushing's syndrome. J Clin Endocrinol Metab, 82 (1). pp. 243-246.

Russell-Jones, DL, Bates, AT, Umpleby, AM, Hennessy, TR, Bowes, SB, Hopkins, KD, Jackson, N, Kelly, J, Shojaee-Moradie, F and Jones, RH (1995) A comparison of the effects of IGF-I and insulin on glucose metabolism, fat metabolism and the cardiovascular system in normal human volunteers. Eur J Clin Invest, 25 (6). pp. 403-411.

Russell-Jones, DL, Umpleby, AM, Hennessy, TR, Bowes, SB, Shojaee-Moradie, F, Hopkins, KD, Jackson, NC, Kelly, JM, Jones, RH and Sönksen, PH (1994) Use of a leucine clamp to demonstrate that IGF-I actively stimulates protein synthesis in normal humans. Am J Physiol, 267 (4 Pt 1). E591-E598.

Russell-Jones, DL, Umpleby, AM, Hennessy, TR, Bowes, SB, Shojaee-Moradie, F, Hopkins, KD, Jackson, NC, Kelly, JM, Jones, RH and Sonksen, PH (1994) Use of a leucine clamp to demonstrate that IGF-I actively stimulates protein synthesis in normal humans American Journal of Physiology - Endocrinology and Metabolism, 267 (4 30-4).

Conference or Workshop Item

Shojaee-Moradie, F, Cuthbertson, DJ, Kemp, GJ, Barrett, M, Jackson, NC, Batt, J, Herring, RA, Wright, J, Russell-Jones, D, Thomas, EL, Bell, J and Umpleby, AM (2015) EXERCISE TRAINING ALTERS VLDL TG AND APOB METABOLISM IN MEN WITH NON-ALCOHOLIC LIVER DISEASE (NAFLD) In: 83rd Congress of the European-Atherosclerosis-Society (EAS), 2015-03-22 - 2015-03-25, Glasgow, SCOTLAND.

Herring, R, Shojaee-Moradie, F, Umpleby, M, Jackson, N, Jones, R, Derk-Jan, D, Knight, R and Russell-Jones, D (2014) Subcutaneous insulin detemir compared with NPH insulin increases brain potential responses with similar systemic metabolic effects in people with Type 1 diabetes

Alsini, N, Shojaee-Moradie, F, Sheldon, B, Robertson, MD, Russell-Jones, DL, Umpleby, AM and Wright, J (2011) Effect of insulin detemir on adipocyte lipid metabolism in patients with type 2 diabetes In: 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), 2011-09-12 - 2011-09-16, Lisbon, PORTUGAL.

Shojaee-Moradie, F, Backhouse, K, Sarac, I, Stoliniski, M, Robertson, D, Bell, JD, Thomas, EL, Russell-Jones, D and Umpleby, M (2010) Fatty acid oxidation rate is higher in obese women than obese men In: 46th Annual Meeting of the European-Association-for-the- Study-of-Diabetes (EASD), 2010-09-20 - 2010-09-24, Stockholm, SWEDEN.

Zachariah, S, Sheldon, B, Shojaee-Moradie, E, Jackson, N, Backhouse, K, Johnsen, S, Umpleby, M and Russell-Jones, D (2010) Mechanism for the differential effect of the long-acting insulin analog detemir on weight in patients with type 1 diabetes In: 46th Annual Meeting of the European-Association-for-the- Study-of-Diabetes (EASD), 2010-09-20 - 2010-09-24, Stockholm, SWEDEN.

Smeeton, FJ, Shojaee-Moradie, E, Jackson, N, Jones, RH, Umpleby, AM and Russell-Jones, D (2007) Is insulin detemir hepatoselective when compared to NPH insulin using stable isotope methodology at plasma glucose concentrations of less than 4 mmol/l? In: 43rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes, 2007-09-18 - 2007-09-21, Amsterdam, NETHERLANDS.

Smeeton, FJ, Shojaee-Moradie, F, Jackson, N, Westergaard, L, Endahl, L, Haahr, H, Umpleby, AM and Russell-Jones, D (2007) No difference in cognitive function, symptoms or counter-regulatory responses after induced hypoglycaemia in subjects with type 1 diabetes In: 67th Annual Meeting of the American-Diabetes-Association, 2007-06-22 - 2007-06-26, Chicago, IL.

Brackenridge, AL, Pearson, ER, Shojaee-Moradie, F, Hattersley, AT, Russell-Jones, D and Umpleby, AM (2005) Subjects with HNF-1 beta mutations have isolated insulin resistance of endogenous glucose production rate in contrast to normal insulin sensitivity in subjects with HNF-1 alpha mutations In: 41st Annual Meeting of the European-Association-for-the-Study-of-Diabetes, 2005-09-10 - 2005-09-15, Athens, GREECE.

Brackenridge, AL, Jackson, N, Shojaee-Moradie, F, Umpleby, AM and Russell-Jones, D (2005) The effect of rosiglitazone and pioglitazone on VLDL apolipoprotein B metabolism in patients with type 2 diabetes In: 65th Annual Meeting of the American-Diabetes-Association, 2005-06-10 - 2005-06-14, San Diego, CA.

Hordern, V, Wright, J, Umpleby, M, Jacobsen, L and Russell-Jones, D (2003) Stable isotope studies show differences in effect of lnsulin detemir and NPH on hepatic glucose output after subcutaneous administration in subjects with type 2 diabetes mellitus In: 63rd Scientific Sessions of the American-Diabetes-Association, 2003-06-13 - 2003-06-17, NEW ORLEANS, LOUISIANA.

McGovern, A, Rafiq, M, Munro, N, Butler, L, Russell-Jones, D, Jones, S, Hinchcliffe, R and de Lusignan, S Peripheral Sensory Neuropathy is a Predictor of Mortality in People with Diabetes In: 73 Scientific Sessions of the American Diabetes Association, 2013-06-21 - 2013-06-25, Chicago.

This list was generated on Sun Sep 24 19:43:02 2017 UTC.

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800